Inhibition of Chlamydia trachomatis Growth During the Last Decade: A Mini-Review

Author(s): Nawal Serradji* , Thi Huyen Vu , Hyunjoon Kim , Jayanth Panyam , Philippe Verbeke .

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 18 , Issue 16 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Chlamydia trachomatis is responsible for the most frequent sexually transmitted bacterial infection in the world and for trachoma, the world's leading infectious cause of blindness. Genital chlamydial infection is very common among sexually active young people, and when untreated, leads to serious complications. No vaccine is yet available for this bacterial infection. Although Chlamydia resistance to antibiotics is rarely observed in vivo, studies showed that 10-20% of patients remain infected at the end of antibiotherapy, without being reinfected. The present review gives a global and comprehensive overview of the different targets and the related inhibitors proposed during the last decade, with a view to limiting the growth of this human pathogen. Metallic and polymeric nanoparticles in this field are also briefly presented.

Keywords: Gram-negative bacteria, inclusion, infection, inhibition, nanoparticles, Chlamydia trachomatis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [1363 - 1372]
Pages: 10
DOI: 10.2174/1389557518666180423152613
Price: $58

Article Metrics

PDF: 25